RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025

July 28, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Google +Pinterest

Walker Lane Resources Ltd. Receives Positive Results from...

Blackstone Completes Share Purchase Plan

Crypto Market Recap: Coinbase Launches Stablecoin Payments, Arizona...

Element79 Gold Corp. Provides Corporate Guidance and Strategic...

Blackstone Minerals Corporate Update

Biotech and Pharma Market Update: Q2 2025 in...

Brunswick Exploration Has Now Identified Four Major New...

Jp Cortez: Is America’s Gold Really There? US...

Athena Gold Completes Till Survey At Laird Lake...

White House Unveils 90-Point AI Strategy

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

Questcorp Mining Taps National Inflation Association for Marketing & Investor Outreach Campaign
Blackstone Completes Share Purchase Plan
Comet share sale and debt repayment
Agreement to Develop New Expandable Graphite Facility
RAD receives IND approval from US FDA for Betabart (RV-01)

Categories

Business (70)
Investing (516)
Politics (699)
World (263)

About us
Contacts
Privacy Policy
Terms & Conditions
Email Whitelisting

Disclaimer: trendfutureincome.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Back To Top

RAD receives IND approval from US FDA for Betabart (RV-01)

Maiden Drill Program Commences at Oasis Uranium Project

Agreement to Develop New Expandable Graphite Facility

You may also like